Navigation Links
PharmacoFore's Bio-Activated Molecular Delivery™ and MPAR™ Technologies to be Introduced by Dr. Lynn Webster at the 27th Annual American Academy of Pain Medicine Meeting
Date:3/25/2011

ican Psychological Association, International Psycho-Oncology Society and American Society of Psychiatric Oncology/AIDS. Additionally, Dr. Passik has written extensively on the interface of pain management and addiction.

About PharmacoFore, Inc.

PharmacoFore, Inc., is a privately held biopharmaceutical company focused on creating novel medicines to improve upon the therapeutic utility of existing drugs, enhance patient care, and prevent the misuse, abuse, and overdose of prescription medications.  The Company's novel Bio-Activated Molecular Delivery™ system (also referred to as Bio-MD™), in contrast to current approaches, effectively addresses abuse via injection and inhalation, as well as abuse via the more common oral route (e.g., chewing pills prior to ingestion).  PharmacoFore will announce the results of its Bio-MD human proof-of-concept study in 2Q'11.

PharmacoFore has also created a complementary technology, MPAR™, uniquely applicable to drugs with its Bio-MDs' mechanism of activation, which provides multi-pill abuse-resistance – that is, oral overdose protection.  When several doses of  MPAR-protected drugs are co-ingested, the systemic exposure of the opioid drug is dramatically limited, without the use of opioid antagonists, such as naloxone, which may expose a patient to additional risks.  Ultimately, PharmacoFore's technology will (1) provide patients with the best treatment option for moderate-to-severe pain; (2) address the worldwide under-treatment of pain; (3) offer a comprehensive solution to the rapidly growing global issue of prescription drug abuse, and; (4) for the first time, provide protection against oral routes of abuse.

About Prescription Drug Abuse

Prescription drug abuse and addiction are major burdens to American society, resulting in significant costs, illness and deaths.  More than 48 million Americans abuse prescription drugs in thei
'/>"/>

SOURCE PharmacoFore, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Molecular Devices, Inc. and ChanTest Corporation Sign Cell Line Distribution Agreement
2. Quest Diagnostics to Acquire Celera, Strengthening Position as Worlds Leading Innovator in Molecular Diagnostics and Development
3. New Technologies Open the Door for Low Dose Breast-Specific Gamma Imaging (BSGI) / Molecular Breast Imaging (MBI)
4. DNA Direct Announces New Health Plan Clients Managing Molecular Diagnostic and Genetic Tests
5. Intelligent Medical Devices, Inc. (IMDx) Enters into an Agreement with Abbott for the Distribution of a Broad Menu of Molecular Tests
6. Caliper and Seegene Partner to Provide Innovative Multiplex Molecular Diagnostics Products
7. New Amplified Molecular Tests Promise to Help Improve Diagnosis and Treatment of Herpes Patients
8. Reportlinker Adds Molecular Diagnostics in Cancer Testing
9. WaferGen and Integrated BioBank of Luxembourg (IBBL) Sign Strategic Agreement for Molecular Diagnostic Research Collaboration and Purchase of SmartChip System
10. Joseph Perrone Joins SRI International to Direct Molecular Diagnostics and Rare and Neglected Diseases Group
11. Ardea Announces Data on MEK Inhibitor BAY 86-9766 (RDEA119) to be Presented at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... NEW YORK , May 6, 2015  The ... ("GEVA" or the "Company") by Alexion Pharmaceuticals, Inc. ("Alexion") ... action, shareholder rights law firm, for possible breaches of ... Board of Directors of GEVA for agreeing to sell ... Company announced a definitive agreement for Alexion to acquire ...
(Date:5/6/2015)... Inc. (NASDAQ: SQNM ), a life sciences company committed ... and services, today reported total revenues of $37.8 million for ... to revenues of $37.1 million for the first quarter of ... $0.12 per share, basic and $0.11 per share, diluted, for ... $15.7 million, or $0.13 per share, basic and diluted, for ...
(Date:5/6/2015)... Inc. (Vanda) (NASDAQ: VNDA ), today announced financial ... 31, 2015. "The first quarter of 2015 ... HETLIOZ and Fanapt.  As we are just at the ... U.S., the growth potential for HETLIOZ remains ahead.  Similarly, ... potential of this product through the coming decade and ...
Breaking Medicine Technology:WeissLaw LLP Investigates the Synageva Biopharma Corp. Acquisition 2Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 2Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 3Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 4Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 5Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 6Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 7Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 8Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 9Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 10Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 11Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 12Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 2Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 3Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 4Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 5Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 6Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 7Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 8Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 9Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 10Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 11Vanda Pharmaceuticals Reports First Quarter 2015 Financial Results 12
... Group Inc. (Nasdaq: WWIN ) ("Winner Medical" or ... medical dressings and consumer products made from 100% cotton, today ... September 30, 2011. Fiscal ... 30.3% to $149.9 million from $115.0 million in the prior ...
... 2011  Watson Pharmaceuticals, Inc. (NYSE: WPI ) ... authorized generic version of LIPITOR® (atorvastatin calcium ... Inc.  Watson began shipping the product today.  LIPITOR® ... reduce elevated total cholesterol, LDL, triglycerides and to increase ...
Cached Medicine Technology:Winner Medical Reports Full Fiscal Year 2011 Results 2Winner Medical Reports Full Fiscal Year 2011 Results 3Winner Medical Reports Full Fiscal Year 2011 Results 4Winner Medical Reports Full Fiscal Year 2011 Results 5Winner Medical Reports Full Fiscal Year 2011 Results 6Winner Medical Reports Full Fiscal Year 2011 Results 7Winner Medical Reports Full Fiscal Year 2011 Results 8Winner Medical Reports Full Fiscal Year 2011 Results 9Winner Medical Reports Full Fiscal Year 2011 Results 10Winner Medical Reports Full Fiscal Year 2011 Results 11Winner Medical Reports Full Fiscal Year 2011 Results 12Winner Medical Reports Full Fiscal Year 2011 Results 13Winner Medical Reports Full Fiscal Year 2011 Results 14Winner Medical Reports Full Fiscal Year 2011 Results 15Winner Medical Reports Full Fiscal Year 2011 Results 16Winner Medical Reports Full Fiscal Year 2011 Results 17Watson Launches Generic LIPITOR® 2Watson Launches Generic LIPITOR® 3
(Date:5/6/2015)... FL (PRWEB) May 06, 2015 Qushanna Doby ... outside a nearby drug treatment center in Florida while under ... on May 4th. New surveillance tapes released by CBS4’s Peter ... without her baby. Doby’s child is around one year old. ... crying and shivering outside was not named. The residents polled ...
(Date:5/6/2015)... 05, 2014 (PRWEB) May 06, 2015 ... accepted, on behalf of MEBC, an Alliance Award ... JDA Software during FOCUS 2015, JDA’s annual user ... the manufacturing, retail and wholesale distribution sectors. This ... their clients are receiving services that advance their ...
(Date:5/6/2015)... Baltimore, MD (PRWEB) May 06, 2015 The ... Baltimore Ravens for the 6th annual charity softball ... 7:00pm at M & T Bank Stadium. Past years guests ... among others. Tickets are still on sale if ... been advocating for local non-profit organizations, such as SOAR ...
(Date:5/6/2015)... Jacksonville, Fla. (PRWEB) May 06, 2015 ... Orthopaedic Institute are the first in north Florida ... This technology is the latest innovation in total ... a highly advanced, surgeon-controlled robotic arm that enables ... Baptist Medical Center Jacksonville has offered MAKOplasty® partial ...
(Date:5/6/2015)... of Prussia, PA (PRWEB) May 06, 2015 ... Process Outsourcing solutions to the Medicare Advantage, Medicare Part ... finalists in the Continuity and Resilience Team category at ... the Business Continuity Institute to recognize the outstanding contribution ... operating in the North America Region, including the USA ...
Breaking Medicine News(10 mins):Health News:Flakka Induced Mother Abandons Baby, found by Florida Drug Treatment Center; New Video Released 2Health News:MEBC Receives Award for Consulting Excellence in Retail 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 4Health News:TMG Health Recognized by the Business Continuity Institute 2Health News:TMG Health Recognized by the Business Continuity Institute 3
... PITTSBURGH , Feb. 12 Pittsburgh ... free antibiotics program in September of 2009, and is pleased ... $3 million in free prescriptions for customers in ... 590,000 prescriptions for free antibiotics have been filled by the ...
... , World-Renowned Policy Experts Held International ... , Global Town Hall Discussed How to Feed ... , WASHINGTON , Feb. 12 ... blizzard today to identify solutions for the greatest agricultural challenges of ...
... NEW YORK , Feb. 12 Dr. Jennifer Muller ... as the 2009 Veterinarian of the Year by Summit VetPharm® at the ... Show Dogs of the Year ® Awards, presented by Dogs In ... a leader in efforts to improve living conditions and strengthen regulations at ...
... , SHANGHAI , Feb. 12 ... of nutritional products, announced today that it, together with its parent ... strategic partnership with Bright Food (Group) Co., LTD (Bright Food). The ... ,s nutritional products market. Bright Food , a leading state-owned ...
... 12, 2010Hypnosis has potential therapeutic value in children with ... or unexplained sensations of difficulty breathing and for lessening ... hypnosis as an adjunct to conventional treatment and its ... physiological changes are explored in a provocative paper in ...
... than ,typical, flu season , FRIDAY, Feb. 12 (HealthDay News) ... federal health officials said Friday that about 57 million Americans ... total could range as high as 84 million. , In ... estimates that as many as 378,000 people were hospitalized due ...
Cached Medicine News:Health News:Giant Eagle Pharmacy Free Antibiotics Program Surpasses $3 Million in Free Prescriptions 2Health News:Now Serving 9 Billion: A Global Town Hall 2Health News:Now Serving 9 Billion: A Global Town Hall 3Health News:Now Serving 9 Billion: A Global Town Hall 4Health News:Dr. Jennifer Muller Named Veterinarian of the Year 2Health News:GNC Announces Entry to China's Nutritional Products in Partnership with Bright Food 2Health News:GNC Announces Entry to China's Nutritional Products in Partnership with Bright Food 3Health News:GNC Announces Entry to China's Nutritional Products in Partnership with Bright Food 4Health News:Hypnosis can relieve symptoms in children with respiratory diseases 2Health News:57 Million Americans Sickened by H1N1 Flu: CDC 2Health News:57 Million Americans Sickened by H1N1 Flu: CDC 3
... the "Consensus Concept" approach to design by ... of a Scientific Advisory Board. The result ... state-of-the-art features. Consensus Knee implants are designed ... and allow near normal kinematics. The components ...
The major innovations in posterior stabilized (PS) knee design....
The GENESIS II* Total Knee System will define the state of knee implants....
... system's curved-on-curved articulation maintains full inter-changeability. ... options for better patient fit. The ... spray porous coating, which offers an ... processed polyethylene is used for consistent, ...
Medicine Products: